Lv11
14 积分 2024-09-03 加入
Low antioxidant status of serum bilirubin, uric acid, albumin and creatinine in patients with myasthenia gravis
58分钟前
已完结
Safety and Effectiveness of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance in Japan
1个月前
已完结
Perioperative Safety and Efficacy of Efgartigimod for Thymoma-Associated Myasthenia Gravis: A Prospective, Multicenter, Phase II Clinical Trial
2个月前
已完结
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis
2个月前
已完结
Single-institution experience with efgartigimod in patients with GFAP astrocytopathy: Treatment response and adverse events
2个月前
已完结
Efgartigimod as adjunctive therapy in refractory autoimmune glial fibrillary acidic protein astrocytopathy: a case series
2个月前
已完结
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
2个月前
已完结
Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study
2个月前
已完结
Evaluation of Sustained Disease Control With Nipocalimab Versus Placebo in the Phase 3 Vivacity-MG3 Study
2个月前
已完结
Clinical efficacy and cost per improved outcome of treatments for generalized myasthenia gravis: evidence from a network meta-analysis and cost-per-responder analysis
2个月前
已完结
皖公网安备34019202002308
